DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors
Currently, there are only three FDA-approved
drugs that inhibit human immunodeficiency virus (HIV)
entry-fusion into host cells. The situation is even worse for
enterovirus EV71 infection for which no antiviral therapies are
available. We describe here the discovery of potent entry dual
inhibitors of HIV and EV71. These compounds contain in
their structure three or four tryptophan (Trp) residues linked
to a central scaffold. Critical for anti-HIV/EV71 activity is the
presence of extra phenyl rings, bearing one or two
carboxylates, at the C2 position of the indole ring of each
Trp residue. The most potent derivatives, 22 and 30, inhibit
early steps of the replicative cycles of HIV-1 and EV-A71 by
interacting with their respective viral surfaces (glycoprotein gp120 of HIV and the fivefold axis of the EV-A71 capsid). The high
potency, low toxicity, facile chemical synthesis, and great opportunities for chemical optimization make them useful prototypes
for future medicinal chemistry studies., This work was supported by the Spanish Plan Nacional
(Subprograma Retos) [projects SAF2015-64629-C2-1-R and
SAF2015-64629-C2-2-R (MINECO/FEDER)], the Spanish
“Ministerio de Ciencia, Innovación y Universidades” (project
PID2019-104070RB-C21), and by the Spanish Agencia Estatal
Consejo Superior de Investigaciones Cientifí cas (CSIC,
Projects CSIC-PIE-201980E100 and CSIC-PIE-
201980E028), “The Centers of Excellence” of the KU Leuven
(EF-05/15 and PF-10/18), EU FP7 (FP7/2007−2013)
Project EUVIRNA (Grant 408 Agreement 264286), EU FP7
SILVER (Contract HEALTH-F3-2010-260644), a grant from
the Belgian Interuniversity Attraction Poles (IAP) Phase VIIP7/
45 (BELVIR), and the EU FP7 Industry-Academia
Partnerships and Pathways Project AIROPICO. The Spanish
MEC/MINECO is also acknowledged for grants to B.M.-G.
and O.M.-M. and the China Scholarship Council (CSC) (grant
201403250056) for a grant to L.S. S.H. received a grant from
the Pennsylvania Department of Health using Tobacco CURE
Funds. We also thank Charlotte Vanderheydt, Sandra Claes,
and Evelyne Van Kerckhove for helping with the processing of
the antiviral data. This work has been awarded with the
Janssen (XVIII call) and Esteve (XIX call) prizes within the
“Prizes for Young Researchers of the Spanish Society of
Medicinal Chemistry (SEQT)., Peer reviewed
Project:
EC / FP7 264286
,
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 SAF2015-64629-C2-1-R
,
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 SAF2015-64629-C2-2-R
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-104070RB-C21
View at: http://hdl.handle.net/10261/201513